GlassScriptPhysician profile
Nelly A Heiman
NPI 1033326103
$3,665.44
in general payments reported to CMS, 2019-2025
42 companies · $963 in 2025
The $963 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $133 · 2021: $108 · 2022: $418 · 2023: $584 · 2024: $900 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,447.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $707.72 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $333.83 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $294.19 | 2019-2023 | |
| Medtronic, INC. | $224.90 | 2022-2025 | Signia, Interstim |
| Mayne Pharma Commercial LLC | $195.04 | 2022-2025 | |
| Ethicon US, LLC | $159.74 | 2024 | Stratafix, Evarrest, Enseal |
| Evofem Biosciences, INC. | $139.71 | 2022-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $122.38 | 2020-2025 | |
| Convatec INC. | $103.60 | 2023-2024 | |
| Hologic Sales and Service, LLC | $102.28 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Therapeuticsmd, INC. | $101.98 | 2019-2022 | |
| Tempus Ai, INC | $98.23 | 2025 | Xt Cdx |
| Myovant Sciences INC. | $89.55 | 2021-2022 | |
| Biogen, INC. | $79.23 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $73.06 | 2019-2024 | Paragard T 380a |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $72.92 | 2019 | |
| Pfizer INC. | $68.17 | 2019-2022 | |
| Allotrope Medical, INC | $53.72 | 2021 | |
| Exeltis, USA INC. | $43.94 | 2021-2025 | Slynd |
| Meditrina | $41.04 | 2022-2023 | |
| Smith+Nephew, INC. | $40.86 | 2020-2025 | Pico 7 |
| Baxter Healthcare | $40.84 | 2024 | Perclot |
| Octapharma USA, INC. | $39.76 | 2025 | Fibryga |
| Daiichi Sankyo INC. | $39.27 | 2019 | |
| Avion Pharmaceuticals | $36.70 | 2019-2023 | Balcoltra |
| Avanos Medical | $34.64 | 2023 | On-Q* Pump and Accessories |
| Organon LLC | $34.03 | 2022-2024 | |
| Novo Nordisk INC | $31.17 | 2023-2024 | Wegovy |
| Agile Therapeutics, INC. | $28.94 | 2022-2023 | Twirla |
| Duchesnay USA Incorporated | $23.60 | 2019 | |
| Axonics, INC. | $21.90 | 2023 | Bulkamid, Axonics |
| Dexcom, INC. | $21.38 | 2025 | Dexcom G6 Transmitter |
| Mylan Pharmaceuticals INC. | $21.18 | 2022 | |
| Dilon Technologies, INC. | $19.69 | 2025 | Hemoblast Bellows |
| Boston Scientific Corporation | $18.85 | 2025 | Axonics |
| Heron Therapeutics, INC. | $17.51 | 2023 | Zynrelef |
| Medicem INC. | $16.58 | 2021 | |
| Renovia INC | $16.11 | 2019 | |
| Roche Diagnostics Corporation | $15.93 | 2019 | |
| Acessa Health INC. | $15.68 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.87 | 2019 | |
| Minerva Surgical, INC | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelly Heiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.